Targeting cyclin D-CDK4/6 sensitizes immune-refractory cancer by blocking the SCP3–NANOG axis
- Se Jin Oh
- , Hanbyoul Cho
- , Suhyun Kim
- , Kyung Hee Noh
- , Kwon Ho Song
- , Hyo Jung Lee
- , Seon Rang Woo
- , Suyeon Kim
- , Chel Hun Choi
- , Joon Yong Chung
- , Stephen M. Hewitt
- , Jae Hoon Kim
- , Seungki Baek
- , Kyung Mi Lee
- , Cassian Yee
- , Hae Chul Park
- , Tae Woo Kim
- Korea University
- National Institutes of Health
- Yonsei University
- Korea Research Institute of Bioscience and Biotechnology
- Sungkyunkwan University
- University of Texas MD Anderson Cancer Center
- Fred Hutchinson Cancer Research Center
Research output: Contribution to journal › Article › peer-review
35
Link opens in a new tab
Scopus
citations